Electromed Inc (ELMD) - Total Assets
Based on the latest financial reports, Electromed Inc (ELMD) holds total assets worth $54.91 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Electromed Inc to assess how comfortably operating cash covers total debt obligations.
Electromed Inc - Total Assets Trend (2008–2025)
This chart illustrates how Electromed Inc's total assets have evolved over time, based on quarterly financial data. See ELMD total equity for net asset value and shareholders' equity analysis.
Electromed Inc - Asset Composition Analysis
Current Asset Composition (June 2025)
Electromed Inc's total assets of $54.91 Million consist of 83.8% current assets and 16.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 28.4% |
| Accounts Receivable | $25.70 Million | 47.8% |
| Inventory | $3.30 Million | 6.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.32 Million | 2.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2008–2025)
This chart illustrates how Electromed Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Electromed Inc (ELMD) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Electromed Inc's current assets represent 83.8% of total assets in 2025, an increase from 69.7% in 2008.
- Cash Position: Cash and equivalents constituted 28.4% of total assets in 2025, up from 15.3% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 1.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 47.8% of total assets.
Electromed Inc Competitors by Total Assets
Key competitors of Electromed Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
APT Medical Inc
SHG:688617
|
China | CN¥3.43 Billion |
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
|
China | CN¥1.59 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.02 Billion |
Electromed Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.86 | 5.10 | 7.62 |
| Quick Ratio | 4.49 | 4.74 | 7.09 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $36.19 Million | $35.52 Million | $28.05 Million |
Electromed Inc - Advanced Valuation Insights
This section examines the relationship between Electromed Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.66 |
| Latest Market Cap to Assets Ratio | 4.14 |
| Asset Growth Rate (YoY) | 3.0% |
| Total Assets | $53.80 Million |
| Market Capitalization | $222.85 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Electromed Inc's assets at a significant premium (4.14x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Electromed Inc's assets grew by 3.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Electromed Inc (2008–2025)
The table below shows the annual total assets of Electromed Inc from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $53.80 Million | +3.00% |
| 2024-06-30 | $52.23 Million | +14.03% |
| 2023-06-30 | $45.81 Million | +10.74% |
| 2022-06-30 | $41.36 Million | +11.47% |
| 2021-06-30 | $37.11 Million | +11.62% |
| 2020-06-30 | $33.24 Million | +13.25% |
| 2019-06-30 | $29.35 Million | +10.20% |
| 2018-06-30 | $26.64 Million | +15.51% |
| 2017-06-30 | $23.06 Million | +12.01% |
| 2016-06-30 | $20.59 Million | +18.28% |
| 2015-06-30 | $17.41 Million | +10.21% |
| 2014-06-30 | $15.79 Million | -10.05% |
| 2013-06-30 | $17.56 Million | -16.09% |
| 2012-06-30 | $20.92 Million | +0.25% |
| 2011-06-30 | $20.87 Million | +47.55% |
| 2010-06-30 | $14.14 Million | +23.40% |
| 2009-06-30 | $11.46 Million | +21.98% |
| 2008-06-30 | $9.40 Million | -- |
About Electromed Inc
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as we… Read more